Arthroplasty
Arthroplasty market is segmented by players, region (country), by Type and by Application. Player ... Read More
Global Arthritis Drug Market Research Report 2024
1 Arthritis Drug Market Overview
1.1 Product Overview and Scope of Arthritis Drug
1.2 Arthritis Drug Segment by Type
1.2.1 Global Arthritis Drug Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Synthetic DMARDs
1.2.3 Biological DMARDs
1.2.4 NSAIDs
1.2.5 Corticosteroids
1.2.6 Analgesics
1.3 Arthritis Drug Segment by Application
1.3.1 Global Arthritis Drug Sales Comparison by Application: (2022-2028)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Drug Stores
1.3.5 E-Commerce
1.4 Global Arthritis Drug Market Size Estimates and Forecasts
1.4.1 Global Arthritis Drug Revenue 2017-2028
1.4.2 Global Arthritis Drug Sales 2017-2028
1.4.3 Arthritis Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Arthritis Drug Market Competition by Manufacturers
2.1 Global Arthritis Drug Sales Market Share by Manufacturers (2017-2022)
2.2 Global Arthritis Drug Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Arthritis Drug Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Arthritis Drug Manufacturing Sites, Area Served, Product Type
2.5 Arthritis Drug Market Competitive Situation and Trends
2.5.1 Arthritis Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Arthritis Drug Players Market Share by Revenue
2.5.3 Global Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Arthritis Drug Retrospective Market Scenario by Region
3.1 Global Arthritis Drug Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Arthritis Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Arthritis Drug Market Facts & Figures by Country
3.3.1 North America Arthritis Drug Sales by Country
3.3.2 North America Arthritis Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Arthritis Drug Market Facts & Figures by Country
3.4.1 Europe Arthritis Drug Sales by Country
3.4.2 Europe Arthritis Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Arthritis Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Arthritis Drug Sales by Region
3.5.2 Asia Pacific Arthritis Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Arthritis Drug Market Facts & Figures by Country
3.6.1 Latin America Arthritis Drug Sales by Country
3.6.2 Latin America Arthritis Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Arthritis Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Arthritis Drug Sales by Country
3.7.2 Middle East and Africa Arthritis Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Arthritis Drug Historic Market Analysis by Type
4.1 Global Arthritis Drug Sales Market Share by Type (2017-2022)
4.2 Global Arthritis Drug Revenue Market Share by Type (2017-2022)
4.3 Global Arthritis Drug Price by Type (2017-2022)
5 Global Arthritis Drug Historic Market Analysis by Application
5.1 Global Arthritis Drug Sales Market Share by Application (2017-2022)
5.2 Global Arthritis Drug Revenue Market Share by Application (2017-2022)
5.3 Global Arthritis Drug Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Arthritis Drug Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Novartis Arthritis Drug Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Arthritis Drug Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Eli Lilly Arthritis Drug Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Celltrion
6.3.1 Celltrion Corporation Information
6.3.2 Celltrion Description and Business Overview
6.3.3 Celltrion Arthritis Drug Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Celltrion Arthritis Drug Product Portfolio
6.3.5 Celltrion Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Corporation Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Arthritis Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 F. Hoffmann-La Roche Arthritis Drug Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Arthritis Drug Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Pfizer Arthritis Drug Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Arthritis Drug Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Johnson & Johnson Arthritis Drug Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Arthritis Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 GSK Arthritis Drug Product Portfolio
6.7.5 GSK Recent Developments/Updates
7 Arthritis Drug Manufacturing Cost Analysis
7.1 Arthritis Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Arthritis Drug
7.4 Arthritis Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Arthritis Drug Distributors List
8.3 Arthritis Drug Customers
9 Arthritis Drug Market Dynamics
9.1 Arthritis Drug Industry Trends
9.2 Arthritis Drug Market Drivers
9.3 Arthritis Drug Market Challenges
9.4 Arthritis Drug Market Restraints
10 Global Market Forecast
10.1 Arthritis Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Arthritis Drug by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Arthritis Drug by Type (2023-2028)
10.2 Arthritis Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Arthritis Drug by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Arthritis Drug by Application (2023-2028)
10.3 Arthritis Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Arthritis Drug by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Arthritis Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Arthritis Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Arthritis Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Arthritis Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Arthritis Drug Market Competitive Situation by Manufacturers in 2021
Table 5. Global Arthritis Drug Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Arthritis Drug Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Arthritis Drug Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Arthritis Drug Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Arthritis Drug Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Arthritis Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Arthritis Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Arthritis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arthritis Drug as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Arthritis Drug Sales by Region (2017-2022) & (K Units)
Table 16. Global Arthritis Drug Sales Market Share by Region (2017-2022)
Table 17. Global Arthritis Drug Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Arthritis Drug Revenue Market Share by Region (2017-2022)
Table 19. North America Arthritis Drug Sales by Country (2017-2022) & (K Units)
Table 20. North America Arthritis Drug Sales Market Share by Country (2017-2022)
Table 21. North America Arthritis Drug Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Arthritis Drug Revenue Market Share by Country (2017-2022)
Table 23. Europe Arthritis Drug Sales by Country (2017-2022) & (K Units)
Table 24. Europe Arthritis Drug Sales Market Share by Country (2017-2022)
Table 25. Europe Arthritis Drug Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Arthritis Drug Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Arthritis Drug Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Arthritis Drug Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Arthritis Drug Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Arthritis Drug Revenue Market Share by Region (2017-2022)
Table 31. Latin America Arthritis Drug Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Arthritis Drug Sales Market Share by Country (2017-2022)
Table 33. Latin America Arthritis Drug Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Arthritis Drug Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Arthritis Drug Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Arthritis Drug Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Arthritis Drug Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Arthritis Drug Revenue Market Share by Country (2017-2022)
Table 39. Global Arthritis Drug Sales by Type (2017-2022) & (K Units)
Table 40. Global Arthritis Drug Sales Market Share by Type (2017-2022)
Table 41. Global Arthritis Drug Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Arthritis Drug Revenue Share by Type (2017-2022)
Table 43. Global Arthritis Drug Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Arthritis Drug Sales (K Units) by Application (2017-2022)
Table 45. Global Arthritis Drug Sales Market Share by Application (2017-2022)
Table 46. Global Arthritis Drug Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Arthritis Drug Revenue Share by Application (2017-2022)
Table 48. Global Arthritis Drug Price by Application (2017-2022) & (USD/Unit)
Table 49. Novartis Corporation Information
Table 50. Novartis Description and Business Overview
Table 51. Novartis Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Novartis Arthritis Drug Product
Table 53. Novartis Recent Developments/Updates
Table 54. Eli Lilly Corporation Information
Table 55. Eli Lilly Description and Business Overview
Table 56. Eli Lilly Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Eli Lilly Arthritis Drug Product
Table 58. Eli Lilly Recent Developments/Updates
Table 59. Celltrion Corporation Information
Table 60. Celltrion Description and Business Overview
Table 61. Celltrion Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Celltrion Arthritis Drug Product
Table 63. Celltrion Recent Developments/Updates
Table 64. F. Hoffmann-La Roche Corporation Information
Table 65. F. Hoffmann-La Roche Description and Business Overview
Table 66. F. Hoffmann-La Roche Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. F. Hoffmann-La Roche Arthritis Drug Product
Table 68. F. Hoffmann-La Roche Recent Developments/Updates
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Business Overview
Table 71. Pfizer Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Pfizer Arthritis Drug Product
Table 73. Pfizer Recent Developments/Updates
Table 74. Johnson & Johnson Corporation Information
Table 75. Johnson & Johnson Description and Business Overview
Table 76. Johnson & Johnson Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Johnson & Johnson Arthritis Drug Product
Table 78. Johnson & Johnson Recent Developments/Updates
Table 79. GSK Corporation Information
Table 80. GSK Description and Business Overview
Table 81. GSK Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. GSK Arthritis Drug Product
Table 83. GSK Recent Developments/Updates
Table 84. Production Base and Market Concentration Rate of Raw Material
Table 85. Key Suppliers of Raw Materials
Table 86. Arthritis Drug Distributors List
Table 87. Arthritis Drug Customers List
Table 88. Arthritis Drug Market Trends
Table 89. Arthritis Drug Market Drivers
Table 90. Arthritis Drug Market Challenges
Table 91. Arthritis Drug Market Restraints
Table 92. Global Arthritis Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 93. Global Arthritis Drug Sales Market Share Forecast by Type (2023-2028)
Table 94. Global Arthritis Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 95. Global Arthritis Drug Revenue Market Share Forecast by Type (2023-2028)
Table 96. Global Arthritis Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 97. Global Arthritis Drug Sales Market Share Forecast by Application (2023-2028)
Table 98. Global Arthritis Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 99. Global Arthritis Drug Revenue Market Share Forecast by Application (2023-2028)
Table 100. Global Arthritis Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 101. Global Arthritis Drug Sales Market Share Forecast by Region (2023-2028)
Table 102. Global Arthritis Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 103. Global Arthritis Drug Revenue Market Share Forecast by Region (2023-2028)
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Arthritis Drug
Figure 2. Global Arthritis Drug Market Share by Type in 2021 & 2028
Figure 3. Synthetic DMARDs Product Picture
Figure 4. Biological DMARDs Product Picture
Figure 5. NSAIDs Product Picture
Figure 6. Corticosteroids Product Picture
Figure 7. Analgesics Product Picture
Figure 8. Global Arthritis Drug Market Share by Application in 2021 & 2028
Figure 9. Retail Pharmacies
Figure 10. Hospital Pharmacies
Figure 11. Drug Stores
Figure 12. E-Commerce
Figure 13. Global Arthritis Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Arthritis Drug Market Size (2017-2028) & (US$ Million)
Figure 15. Global Arthritis Drug Sales (2017-2028) & (K Units)
Figure 16. Arthritis Drug Sales Share by Manufacturers in 2021
Figure 17. Global Arthritis Drug Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest Arthritis Drug Players: Market Share by Revenue in 2021
Figure 19. Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Arthritis Drug Sales Market Share by Region (2017-2022)
Figure 21. Global Arthritis Drug Sales Market Share by Region in 2021
Figure 22. Global Arthritis Drug Revenue Market Share by Region (2017-2022)
Figure 23. Global Arthritis Drug Revenue Market Share by Region in 2021
Figure 24. U.S. Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Canada Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Germany Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. France Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. U.K. Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Italy Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Russia Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Japan Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. South Korea Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. India Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Australia Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Taiwan Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Indonesia Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Thailand Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Malaysia Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Philippines Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Vietnam Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Mexico Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Brazil Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Argentina Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Turkey Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Saudi Arabia Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. U.A.E Arthritis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Sales Market Share of Arthritis Drug by Type (2017-2022)
Figure 49. Manufacturing Cost Structure of Arthritis Drug
Figure 50. Manufacturing Process Analysis of Arthritis Drug
Figure 51. Arthritis Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis Eli Lilly Celltrion F. Hoffmann-La Roche Pfizer Johnson & Johnson GSK